mehealth™ for ADHD Now Available with Spanish Language Capability
The new Spanish language capability in mehealth™ for ADHD facilitates communication between Spanish-speaking parents and their physicians, enabling better patient outcomes for children with ADHD
MARLBOROUGH, Mass., Nov. 10, 2014 /PRNewswire/ -- mehealth, a leader in mental health software solutions, today announced the launch of a Spanish language capability in their mehealth™ for ADHD product. Physicians, families and teachers have used mehealth for ADHD more than 10,000 times to support the individual diagnosis and treatment of children at risk for ADHD. While the assessment of ADHD is traditionally a paper-based process, mehealth for ADHD uses a digital platform to automate the process and make it paperless, subsequently reducing the time it takes to diagnose and treat a patient. Now, mehealth for ADHD's digital platform, which implements American Academy of Pediatrics' (AAP) clinical guidelines and DSM-5, includes a Spanish language component.
The new component of mehealth for ADHD enables Spanish-speaking parents and guardians to complete rating scales about their child's behavior in their native language. These completed rating scales are a vital resource to physicians at the point-of-care, both for diagnosing and managing ADHD. Rating scale assessments, together with complementary assessments provided by the child's teacher, translate into faster, more accurate diagnosis and treatment at the point-of-care. Improved communication between parents and the physician—unhindered by any language barrier—streamlines the physician's diagnosis and treatment process and improves patient outcomes. By efficiently connecting a child with ADHD to a well-fitting treatment plan, clinicians and parents are able to help children with ADHD begin to thrive both socially and academically.
Dr. Janet Munro, chief executive officer at mehealth, comments: "Adding this capability to mehealth for ADHD allows the children of Spanish-speaking parents to receive quality clinical care in our English-speaking healthcare system. When it comes to behavioral healthcare—such as the clinical diagnosis and ongoing treatment of a child with ADHD—much of the process is reliant upon communication between home, school and the physician. The intent of our original clinical tool, mehealth for ADHD, was to provide children with ADHD with quality, individualized treatment as soon as possible. Now, by enabling the option of Spanish language emails and assessments, we have extended that benefit to many more children in the country, whether they live in an English-speaking or a Spanish-speaking household. Better care and equality are essential steps forward."
Dr. Ilan Shapiro, a pediatrician who uses mehealth for ADHD at his Florida physician's practice, comments, "With mehealth for ADHD, parents are not only involved in the process of assessing their child for ADHD, they are truly able to impact the quality of care their child receives, by completing rating scales. With this new Spanish language component, Spanish-speaking parents can feel confident that they are positively contributing to the care their child is receiving, and have the privilege to do so in their native language."
About mehealth:
mehealth™ is a trading brand of Optimal Medicine Inc., a personalized medicine company. mehealth™ for ADHD is a software tool that provides clinical decision support that enables clinicians to deliver individualized quality care, and optimize clinical outcomes, for children with ADHD.
Optimal Medicine is located in Marlborough, Massachusetts (MA); it specializes in software for mental health disorders. Its products enhance the clinical care that patients receive, improving clinical outcomes, enhancing efficiency in the clinic and reducing care costs. This is achieved by collecting, analyzing and delivering relevant data to physicians at the point-of-care and at the time when key clinical decisions are made.
For more information please visit: http://www.mehealth.com. The company also has a presence on Twitter (@mehealthADHD), LinkedIn, and Facebook.
Editor's Notes:
- All mehealth news releases (financial, acquisitions, products, technology etc.) are issued exclusively by PR Newswire and are immediately thereafter posted on the company's external website, www.mehealth.com
- Optimal Medicine, mehealth, and the mehealth logo design are trademarks of Optimal Medicine, Inc.
- All other brand or product names may be trademarks or registered trademarks of their respective companies.
For more information, contact:
Ceara O'Sullivan
Next Step Communications
315-567-2528
[email protected]
SOURCE Optimal Medicine, Inc.
Share this article